CD79A and autoimmune polyendocrinopathy: Routine IgA aCL/aβ2GPI measurement is not recommended as added value of IgA aPL to the current laboratory criteria for diagnosis and risk stratification of APS is limited and analytical variation is high with a lack of standardization across assays.